Experimental validation of predicted miRNA targets revealed an increase in the expression of focal adhesion kinase (PTK2) genes (Fig 5B), implicating EV-mediated miRNA transfer in high grade, aggressive osteosarcomas, in agreement with previous observations [30, 31]. Here, PTK2 is linked to osteosarcoma.